Stephen Kanes, Chief Medical Officer at Sage Therapeutics, Inc. (SAGE), sold 74,300 shares at $176.53 ($13.2M) on 2018-01-10, disclosed to the SEC on 2018-01-12.
Open-market sale of $13.2M SAGE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $170.67 | 600 | $102K | 0.8% |
| 2 | $170.67 | 600 | $102K | 0.8% |
| 3 | $171.80 | 1,200 | $206K | 1.6% |
| 4 | $173.09 | 1,200 | $208K | 1.6% |
| 5 | $174.35 | 2,200 | $384K | 2.9% |
| 6 | $175.03 | 2,461 |
| $431K |
| 3.3% |
| 7 | $175.03 | 2,461 | $431K | 3.3% |
| 8 | $176.53 | 11,057 | $2.0M | 14.8% |
| 9 | $176.53 | 11,057 | $2.0M | 14.8% |
| 10 | $177.48 | 9,100 | $1.6M | 12.3% |
| 11 | $178.33 | 6,923 | $1.2M | 9.4% |
| 12 | $178.33 | 6,923 | $1.2M | 9.4% |
| 13 | $179.61 | 7,859 | $1.4M | 10.7% |
| 14 | $179.61 | 7,859 | $1.4M | 10.7% |
| 15 | $180.11 | 1,400 | $252K | 1.9% |
| 16 | $180.11 | 1,400 | $252K | 1.9% |
| Total | $177.38 avg | 74,300 | $13.2M | 100% |
| Filing → |
| SAGE | SELL | 2015-09-29 | $279K | — | Filing → |
| SAGE | SELL | 2015-09-01 | $637K | — | Filing → |
| SAGE | SELL | 2015-07-29 | $347K | — | Filing → |